SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001193125-19-015661
Filing Date
2019-01-24
Accepted
2019-01-24 13:09:04
Documents
3
Group Members
CANAAN PARTNERS X LLC

Document Format Files

Seq Description Document Type Size
1 SC 13G/A d682193dsc13ga.htm SC 13G/A 69784
2 EX-24 d682193dex24.htm EX-24 13791
3 EX-99.1 d682193dex991.htm EX-99.1 3874
  Complete submission text file 0001193125-19-015661.txt   89178
Mailing Address 7707 GATEWAY BLVD., SUITE 140 NEWARK CA 94560-1160
Business Address 7707 GATEWAY BLVD., SUITE 140 NEWARK CA 94560-1160 (510) 474-0170
Protagonist Therapeutics, Inc (Subject) CIK: 0001377121 (see all company filings)

IRS No.: 980505495 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-89601 | Film No.: 19539214
SIC: 2834 Pharmaceutical Preparations

Mailing Address 285 RIVERSIDE AVE. SUITE 250 WESTPORT CT 06880
Business Address 285 RIVERSIDE AVE. SUITE 250 WESTPORT CT 06880 203-855-0400
CANAAN X L.P. (Filed by) CIK: 0001619859 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: SC 13G/A